| abstract |
The present invention relates to rapidly disintegrating oral dosage forms , more particularly to Phenyl)cyclopropyl]amino}‑5‑(propylthio) ‑3H‑ [1,2,3]‑triazolo[4,5‑ d ]pyrimidin‑3‑yl]‑5‑(2 -Hydroxyethoxy)cyclopentane-1,2-diol and disintegrating excipients in fast-disintegrating tablets. A blister pack suitable for use with the rapidly disintegrating oral dosage form is also disclosed. |